Carcinoma Clinical Trials

Active, Not Recruiting

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT01142388

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

The Medical Center of Aurora Aurora, Colorado, United States

Boulder Community Foothills Hospital Boulder, Colorado, United States

View all 232 locations

View Trial Details

Active, Not Recruiting

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT02567422

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States

Yale University New Haven, Connecticut, United States

View all 19 locations

View Trial Details

Active, Not Recruiting

Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma

NCT03854474

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States

Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut, United States

View all 34 locations

View Trial Details

Active, Not Recruiting

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

NCT04175912

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 419 locations

View Trial Details

Active, Not Recruiting

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

NCT04071223

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Rush MD Anderson Cancer Center Chicago, Illinois, United States

View all 47 locations

View Trial Details

Active, Not Recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

NCT01272037

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +11 more
Locations: Northeast Alabama Regional Medical Center Anniston, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Providence Hospital Mobile, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

View all 1569 locations

View Trial Details

Active, Not Recruiting

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

NCT04963153

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +36 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

NCT03055013

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Cancer Center at Saint Joseph's Phoenix, Arizona, United States

View all 413 locations

View Trial Details

Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations: Providence Hospital Mobile, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Fairbanks Memorial Hospital Fairbanks, Alaska, United States

Mercy Hospital Fort Smith Fort Smith, Arkansas, United States

View all 780 locations

View Trial Details

Active, Not Recruiting

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

NCT01366144

Conditions: Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

City of Hope South Pasadena South Pasadena, California, United States

Moffitt Cancer Center Tampa, Florida, United States

View all 17 locations

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions